Chinese sales significantly impact Richemont's quarterly accounts; we believe that this is temporary. China sales are up in January 2023. Read more here.Read full newsRead More
Merck has many divisions and has its most ambitious plans are centered around Oncology, Cardiovascular and Vaccines. Read what investors can expect in 2023.Read full newsRead More
Polaris shares declined since I put out my latest cautious piece. Despite this, the shares are still expensive vs. fundamentals. See more on PII stock here.Read full newsRead More
Citigroup offers a depressed valuation and an interesting dividend yield above 4%. Click here to read my analysis of C stock.Read full newsRead More
Assertio Holdings got rights to Sympazan in October. Most Medicare plans cover it. Click to see what this may mean for the future of ASRT stock.Read full newsRead More
Under Armour's brand issues were apparent in 2016 if you knew where to look. UA hasn't crossed over into fashion, and the sales prove it. Read more here.Read full newsRead More
In this article, I will present my views on where NOT to invest in 2023. Click to see my picks of securities to avoid in 2023.Read full newsRead More
I sold out of Krystal Biotech after it hit my 65% profit price target. I am looking for another opportunity to enter KRYS. Click here to read my KRYS review.Read full newsRead More
Natural gas has plummeted in value in the US and Europe as warm weather and higher production aid supply levels. Read more on UNG ETF here.Read full newsRead More
Las Vegas Sands Corp. shares tend to inch up rather than spike as do many of its peers when bullish news breaks. Click here to read my analysis of LVS stock.Read full newsRead More
The article discusses LHX and PFE - two quite recession-resistant businesses that currently trade at compelling valuations and have solid long-term prospects.Read full newsRead More
Tesla, Inc. is remarkably cheap relative to its revenue growth prospects and earnings growth potential. Click here to read my analysis of TSLA stock.Read full newsRead More
Invesco KBW Premium Yield Equity REIT ETF offers investors an attractive option to invest in small-cap REITs in the U.S. Click here for our review of KBWY ETF.Read full newsRead More
Ally Financial's stock price exploded as the company reported better-than-expected revenues and earnings while expecting a slow-down in deteriorating credit quality.Read full newsRead More
State Street Corporation (NYSE:NYSE:STT) Q4 2022 Earnings Conference Call January 20, 2022 11:00 AM ETCompany ParticipantsIlene Fiszel Bieler - EVP and Global Head of IRRonald P.Read full newsRead More
Intercept announced that the FDA has set an action date of June 22nd, 2023 for its second review of Ocaliva in NASH. Click here to read my analysis of ICPT stock.Read full newsRead More
This article seeks to provide a valuation and pricing mechanism for H&R Block Inc. Click here for our analysis of HRB and its prospects in the current environment.Read full newsRead More
After the Juul and Cronos impairment, it appears that Altria is shifting gears and refocusing on its core business segment for now. Read the stock outlook here.Read full newsRead More
Commerce Bancshares' Q4 results were okay; pre-provision profits seem to have missed modestly, but the core drivers were fine. Read my analysis of CBSH stock.Read full newsRead More
Greene County Bancorp, Inc. is a regional bank stock serving the people of upstate New York. Click here to read my earnings analysis of GCBC stock.Read full newsRead More